---
title: "NNNN.US (NNNN.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/NNNN.US/news.md"
symbol: "NNNN.US"
name: "NNNN.US"
parent: "https://longbridge.com/en/quote/NNNN.US.md"
datetime: "2026-03-03T23:55:35.374Z"
locales:
  - [en](https://longbridge.com/en/quote/NNNN.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NNNN.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NNNN.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/NNNN.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/NNNN.US/news.md)


# NNNN.US (NNNN.US) — Related News

### [Generate Biomedicines shares fall 6% in weak Nasdaq debut for drug developer](https://longbridge.com/en/news/277236344.md)
*2026-02-27T18:09:10.000Z*
> Generate Biomedicines shares fell 6.25% in their Nasdaq debut, valuing the company at $1.91 billion. The shares opened a

### [Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering | GENB Stock News](https://longbridge.com/en/news/277124112.md)
*2026-02-26T16:58:00.000Z*
> Generate Biomedicines, Inc. has announced the pricing of its initial public offering (IPO) of 25 million shares at $16.0

### [AI pharmaceutical company Generate Biomedicines IPO priced at $16 per share, landing on Nasdaq tonight](https://longbridge.com/en/news/277153682.md)
*2026-02-27T06:58:03.000Z*
> AI drug development company Generate Biomedicines officially announced an IPO offering price of $16 per share, planning 

### [](https://longbridge.com/en/news/277124145.md)
*2026-02-27T01:13:12.000Z*
> The drug developer Generate Biomedicines announced on Thursday that it raised $400 million in its initial public offerin

### [Drug developer Generate Biomedicines raises $400 million in US IPO](https://longbridge.com/en/news/277125929.md)
*2026-02-27T01:09:00.000Z*
> Generate Biomedicines raised $400 million in its U.S. IPO, pricing shares at $16 each. The offering comes amid a volatil

### [Biotech Firm Generate Biomedicines Plans $425 Million IPO Amid Sector Growth](https://longbridge.com/en/news/276612901.md)
*2026-02-23T14:21:30.000Z*
> Generate Biomedicines, a biotech firm utilizing AI for drug development, plans to raise up to $425 million in an IPO. Th